La Roche-Posay has participated in the prestigious European Association for the Study of Dermatology (EADV) for 30 consecutive years, bringing half a century of scientific research experience to open a new chapter in dermatology.

From September 17 to 20, 2025, the 34th European Academy of Dermatology & Venereology (EADV) Congress was held at the Paris Convention Center in France. The EADV Congress is known as the most authoritative dermatology research conference in Europe and one of the most influential international conferences in the field of dermatology worldwide. As the No.1 recommended skincare brand by global dermatology experts [1], La Roche-Posay, a dermatology-grade scientific skincare brand from France, has appeared at the EADV Congress for 30 consecutive years, bringing a number of innovative scientific research results and rich academic activities to discuss the future development of the field of skin health with dermatology experts from all over the world.

Image: La Roche-Posay EADV booth at the convention.

La Roche-Posay brings together cutting-edge technology and innovative achievements to create an innovative interactive experience .

During the EADV conference, La Roche-Posay's booth featured three main themes, providing attending experts with a comprehensive, immersive product experience and academic exchange opportunities. The brand showcased its comprehensive solutions for protecting and improving different types of pigmentation, including the latest photoprotection technologies and data support. It also systematically shared its practical approach and product application solutions for acne type-specific care, and offered holistic solutions that balance treatment efficacy and quality of life for patients with chronic skin conditions, helping experts develop more comprehensive and personalized care plans for their patients.

Meanwhile, La Roche-Posay invited renowned domestic dermatology experts, Professor Lai Wei and Professor Zou Ying, to the booth for exchanges and interactions, allowing them to experience the innovative ingredients and intelligent technology. Both professors agreed that these innovative technologies provide a more scientific basis for the evaluation of dermatological clinical diagnosis and treatment effects, effectively promoting the optimization of clinical application decisions.

Photo: Professors Lai Wei and Zou Ying interacted with the exhibitors at the booth.

In addition, La Roche-Posay presented 41 academic abstracts at this year's EADV conference, covering various dermatological topics such as future developments in skin health, UV protection, pigmentation issues, repair, skin aging, and tumor-related adverse skin reactions. Among them, five abstracts from Chinese experts discussed research findings on the application of La Roche-Posay B5 Cream, La Roche-Posay B5 Sunscreen, and La Roche-Posay Purple Light Serum to different skin problem groups.

Image: La Roche-Posay poster display

La Roche-Posay brings together leading experts to discuss future trends in dermatology

During this EADV conference, La Roche-Posay created a multi-dimensional professional exchange environment focusing on common skin problems and cutting-edge academic directions, providing a rich platform for academic exchange for participating experts.

On the first day of the conference, La Roche-Posay held a press conference to launch its brand white paper themed "Dermatology in a Changing World: A Vision for the Next 50 Years." Professor Xiang Leihong, a Chinese dermatology expert, along with leading international experts such as Dr. Andrea Rey from Argentina, Professor Jorge Ocampo-Candiani from Mexico, and Dr. Jetty Tan from Canada, provided in-depth analysis of the impact of global trends such as population aging and climate change on skin health, explored cutting-edge applications of dermatology, and offered a forward-looking perspective on the development of skin health.

Photo: Professor Xiang Leihong speaking / Brand White Paper Launch Event

The following day, La Roche-Posay launched a groundbreaking photoprotection study at the L'Oréal Dermatology & Beauty Division satellite conference, providing a better end-to-end solution for pigmentation problems. Professor Henry Lim, President of the International Federation of Dermatological Societies (ILDS), explained the mechanism by which ultraviolet A (UVA) and high-energy visible light (HEVL) cause pigmentation. Dr. Francoise Bernerd of L'Oréal Innovation and Research Center gave a detailed introduction to the new La Roche-Posay Brightening Sunscreen containing L'Oréal Group's proprietary technology Mexoryl 400[2] and Mexoryl®, providing new ideas for photoprotection and pigmentation correction. This sunscreen can not only effectively prevent sunburn and tanning, but also inhibit tanning in the early stages and lighten sun spots, opening up a new sun protection experience.

Image: Speech at the Satellite Symposium

On the third day of the conference, the La Roche-Posay brand symposium, titled "Invisible Scars: A Landmark Epidemiological Study," was held, delving into the long-term impact of atopic dermatitis. Internationally renowned experts, including Professor Seemal Desai from the United States and Professor Andreas Wollenberg from Germany, comprehensively analyzed the profound impact of skin diseases on patients' quality of life from the perspectives of neuroscience and psychodermatology, providing new ideas and methods for practical diagnosis and treatment.

Image: Speech at the brand seminar

50 years of scientific research accumulation, driving the development of the field of skin health through innovation.

For 50 years, La Roche-Posay has adhered to the brand philosophy of "Skin Science, Changing Lives," deeply cultivating the field of scientific skincare. From caring for the delicate skin of newborns to UV protection, to solutions for various skin problems, and the creation of the brand's "Blue Ribbon" program to care for the skin health of cancer patients, La Roche-Posay is committed to transforming cutting-edge scientific research results into practical solutions, helping dermatologists worldwide address the increasingly complex and diverse challenges to skin health.

After 50 years of dedicated work, La Roche-Posay has not only established a comprehensive scientific research system, but also forged deep partnerships with dermatologists worldwide, jointly promoting the development of skin health.

This EADV conference was not only an academic feast for La Roche-Posay, but also a vivid demonstration of the brand's 50 years of professional dedication. The brand hopes to use this EADV conference as an opportunity to establish closer partnerships with dermatologists worldwide, jointly expanding the future boundaries of dermatology, providing safer, more scientific, and effective products, and allowing more consumers to experience the power of scientific skincare.

[1] The conclusions are based on brand recommendations obtained by conducting a survey of 4,727 dermatologists in 31 countries (which account for more than 80% of global GDP) between January 2024 and May 2024, in collaboration with the brand and third-party research institutions.

[2] Mexoryl 400 patent number: 201710328916.3

[3] La Roche-Posay New Protect Lightweight Sunscreen Lotion 400 SPF50+ PA++++ (Whitening and Dark Spot Corrector) *This product is only sold through cross-border e-commerce channels.